
The IMF team is in Tokyo this week. Susie Durie, Lisa Paik, Dan Navid, and I are here for the 43rd Annual Japanese Myeloma Society Meeting, the oldest of the country-based myeloma meetings globally and one of the most active.
It promises to be a busy week.
The Asia-Pacific region is home to approximately 60 percent of all myeloma patients, so it’s fitting that in the meeting’s keynote lecture, I will address the question we researchers constantly ask: “Can we cure or prevent myeloma?”